Baxa's website states that its mission is "to be a greatmedical device company that continually improves and maximizes long-term valuethrough lifetime partnerships with customers." The company's pharmacy productsinclude automated compounding devices, dose management, pharmacy admixturetools, oral and enteral systems, automated filling systems and IVadministration. Baxa also has a variety of nursing products, including suppliesfor neonatal feeding, oral and enteral systems and IV administration. Baxa'sproduct line includes the ExactaMix Compounder, devices that work to automatemulti-ingredient nutritional solution compounding, as well as its DoseEdgePharmacy Workflow Manager, which provides an integrated system for managing IVand oral dose preparation activities.
"With these new offerings, Baxter will be able to provide acomprehensive solution to fulfill the majority of patients' nutritionalrequirements and increase efficiency in the pharmacy," said Robert M. Davis,president of Baxter's Medical Products business, in a press release regardingthe acquisition. "Bringing this expertise together with Baxter's commercialcapabilities and global reach will enable us to continue to meet our customers'evolving needs and extend our position in IV nutrition and fluid delivery."
The acquisition is a strong one for Baxter based on theextremely complementary nature of the two companies' businesses. Baxter's areasof expertise include anesthesia, clinical nutrition, infusion systems/IVtubing, and pharmaceuticals, solutions and drug delivery. When combined withthe company's drug delivery systems and nutrition products—such as Baxter'smulti-chamber, prefilled, premixed containers—Baxa's products will boost thecompany's portfolio and its strength in its areas of focus.
Premixed medications and pharmacy automation serve tominimize issues in the medication process, in terms of reducing errors indosage and administration and improving effectiveness. Baxter's premixedmulti-chamber containers include essential nutrients for a range of patients,and Baxa's integration and automation technology give hospital pharmacists theability to customize treatments for specific patient populations.
